Filter
1739
Filtered Results: 1739
Text search:
European
Medicines
Agency
Featured
Recommendations
163
New Publications
353
Language
Document type
No document type
798
Studies & Reports
419
Guidelines
261
Manuals
110
Strategic & Response Plan
57
Fact sheets
39
Training Material
22
Situation Updates
21
Resource Platforms
5
Brochures
4
App
1
Infographics
1
Online Courses
1
Countries / Regions
Global
102
Western and Central Europe
94
Ukraine
55
Eastern Europe
35
Africa
29
Kenya
28
Ethiopia
25
Ghana
21
Sierra Leone
21
Nigeria
21
Zambia
21
Latin America and the Carribbean
19
Germany
19
Liberia
19
Myanmar / Burma
19
Nepal
18
Syria
18
India
18
Eastern Europe and Central Asia
17
Russia
16
South Africa
15
Guinea
12
South–East Asia Region
12
Philippines
11
Venezuela
11
West and Central Africa
11
Bangladesh
11
Uganda
11
Rwanda
10
Moldova
10
Namibia
10
Malawi
9
Zimbabwe
9
East and Southern Africa
9
Tajikistan
8
Senegal
8
Tanzania
8
Congo, Democratic Republic of
8
Thailand
7
Georgia
7
Indonesia
7
North Macedonia
6
Colombia
6
Burkina Faso
6
Jordan
6
Middle East and North Africa
6
Brazil
6
South Sudan
6
Cameroon
5
Albania
5
Mozambique
5
Cambodia
5
Asia
5
Paraguay
5
Yemen
5
Eswatini/ Swaziland
5
Benin
4
Haiti
4
Hungary
4
Sudan
4
Poland
4
Botswana
4
Somalia
4
Serbia
3
Lesotho
3
Turkey
3
China
3
Kazakhstan
3
Laos
3
Kyrgyzstan
3
Afghanistan
3
USA
3
Jamaica
3
Belarus
3
Lebanon
3
Vietnam
3
Romania
3
Pakistan
3
Chile
2
Iran
2
Estonia
2
Uzbekistan
2
Morocco
2
Bulgaria
2
Western Pacific Region
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Sri Lanka
2
Egypt
2
Central African Republic
2
Libya
2
Iraq
2
Madagascar
2
Mexico
1
El Salvador
1
Australia
1
Niger
1
Peru
1
Mongolia
1
Mauritania
1
Armenia
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Spain
1
Southern Africa
1
Papua New Guinea
1
Slovakia
1
Greece
1
Mali
1
Bhutan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
430
Clinical Guidelines
160
Key Resources
104
Public Health
92
Women & Child Health
80
Pharmacy & Technologies
30
Capacity Building
13
Toolboxes
COVID-19
165
Mental Health
164
HIV
138
TB
124
AMR
111
Planetary Health
83
Conflict
74
Rapid Response
73
Pharmacy
58
Refugee
52
Disability
49
Ebola & Marburg
48
Global Health Education
42
NTDs
33
NCDs
33
Health Financing Toolbox
32
Caregiver
31
Specific Hazards
18
Malaria
17
Zika
15
Natural Hazards
14
Polio
6
Cholera
3
Social Ethics
1
Report of a mission 20–24 April 2015
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in the medical, veterinary and agricultural sectors, which ...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in the medical, veterinary and agricultural sectors, which ...
Namibia has a two-tier health system: public health under the Ministry of Health and Social Services (MoHSS) and the private health service. MoHSS‘ vision is to be the leading provider of quality health care and social services according to international set standards. Since Namibia’s independe...
Front. Trop. Dis. , 09 May 2023 Sec. Neglected Tropical Diseases Volume 4 - 2023 | https://doi.org/10.3389/fitd.2023.1087003
The Lancet Infectious Disease Volume 25, Issue 2e77-e85February 2025
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
